Keenswijk Werner, Vanmassenhove Jill, Raes Ann, Dhont Evelyn, Vande Walle Johan
Department of Pediatrics, Pediatric Nephrology, Ghent University Hospital, Gent, Belgium.
Department of Internal Medicine, Division of Nephrology, Ghent University Hospital, Gent, Belgium.
Eur J Pediatr. 2017 Mar;176(3):355-360. doi: 10.1007/s00431-016-2846-z. Epub 2017 Jan 11.
Diarrhea-associated hemolytic uremic syndrome (D+HUS) is a common thrombotic microangiopathy during childhood and early identification of parameters predicting poor outcome could enable timely intervention. This study aims to establish the accuracy of BUN-to-serum creatinine ratio at admission, in addition to other parameters in predicting the clinical course and outcome. Records were searched for children between 1 January 2008 and 1 January 2015 admitted with D+HUS. A complicated course was defined as developing one or more of the following: neurological dysfunction, pancreatitis, cardiac or pulmonary involvement, hemodynamic instability, and hematologic complications while poor outcome was defined by death or development of chronic kidney disease. Thirty-four children were included from which 11 with a complicated disease course/poor outcome. Risk of a complicated course/poor outcome was strongly associated with oliguria (p = 0.000006) and hypertension (p = 0.00003) at presentation. In addition, higher serum creatinine (p = 0.000006) and sLDH (p = 0.02) with lower BUN-to-serum creatinine ratio (p = 0.000007) were significantly associated with development of complications. A BUN-to-sCreatinine ratio ≤40 at admission was a sensitive and highly specific predictor of a complicated disease course/poor outcome.
A BUN-to-serum Creatinine ratio can accurately identify children with D+HUS at risk for a complicated course and poor outcome. What is Known: • Oliguria is a predictor of poor long-term outcome in D+HUS What is New: • BUN-to-serum Creatinine ratio at admission is an entirely novel and accurate predictor of poor outcome and complicated clinical outcome in D+HUS • Early detection of the high risk group in D+HUS enabling early treatment and adequate monitoring.
腹泻相关溶血尿毒综合征(D+HUS)是儿童期常见的血栓性微血管病,早期识别预测不良预后的参数可实现及时干预。本研究旨在确定入院时血尿素氮与血清肌酐比值以及其他参数在预测临床病程和预后方面的准确性。检索2008年1月1日至2015年1月1日期间因D+HUS入院的儿童记录。复杂病程定义为出现以下一种或多种情况:神经功能障碍、胰腺炎、心脏或肺部受累、血流动力学不稳定和血液学并发症,而不良预后定义为死亡或发展为慢性肾脏病。纳入34名儿童,其中11名患有复杂病程/不良预后。出现复杂病程/不良预后的风险与入院时少尿(p=0.000006)和高血压(p=0.00003)密切相关。此外,较高的血清肌酐(p=0.000006)和sLDH(p=0.02)以及较低的血尿素氮与血清肌酐比值(p=0.000007)与并发症的发生显著相关。入院时血尿素氮与血清肌酐比值≤40是复杂病程/不良预后的敏感且高度特异的预测指标。
血尿素氮与血清肌酐比值可准确识别有复杂病程和不良预后风险的D+HUS儿童。已知:•少尿是D+HUS长期不良预后的预测指标 新发现:•入院时血尿素氮与血清肌酐比值是D+HUS不良预后和复杂临床结局的全新且准确的预测指标 •早期发现D+HUS高危组可实现早期治疗和充分监测。